Skip to Content

EHA24: Danish LBA Shows that Oral Vitamin C Might Improve OS for Patients with Early-Stage Myeloid Malignancies and Precursor Conditions

A Late-Breaking Abstract presented at EHA 2024 by Dr. Stine Ulrik Mikkelsen from Rigshospitalet, Denmark, shows that vitamin C supplementation has shown significant promise for improving survival in patients with low-risk myeloid malignancies and precursor conditions.

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top